Results and press releases

Annual and interim financial reports

This section contains the Labomar annual and interim financial reports for every financial year since 2019.

19 September 2023 Labomar Group achieves B CORP™ certification
07 September 2023 Charterhouse partners with Labomar’s founder to deliver next phase of growth
12 April 2023 Impact Report 2022 Labomar Spa
12 April 2023 Consolidated Financial Statement 2022 Labomar Group
29 September 2022 Consolidated Financial Statements H1 2022 Labomar Group
29 April 2022 Impact Report 2021 Labomar Spa
29 April 2022 Consolidated Financial Statement 2021 Labomar Group
19 April 2021 Impact Report 2020 Labomar Spa
10 September 2021 Consolidated Financial Statements 2020 Labomar Group

Show others

Press releases and financial notices

This section contains the press releases and notices published via the 1INFO system.

20 July 2023 Labomar: consolidated revenues in the first half of 2023 at 53.4 ml.€
27 June 2023 Substantial change of significant Shareholders
04 May 2023 Shareholders’ Meeting held today in addition to Board of Directors’ Meeting
28 April 2023 Shareholders’ Meeting deserted and postponement to 2nd call
20 April 2023 Q1 2023 consolidated revenues up 47%
14 April 2023 Labomar wins the “Voted Product of the Year 2023” award in Spain with 2 references
31 March 2023 Labomar is attending Investor Access Event in Paris next April, 4
29 March 2023 Financial Statement 2022 and Shareholders’ Meeting Call Labomar Spa
15 March 2023 Variation to 2023 Financial Calendar
21 February 2023 EcoVadis assigns “Silver” rating to Labomar
26 January 2023 Labomar consolidated revenues increase to approx. Euro 92 ml. in 2022 (+41,5%)
13 January 2023 2023 Financial Calendar
13 December 2022 Labomar appoints Luciano Marton as the Company’s General Manager
25 November 2022 Labomar is attending “Mid&Small in Milan” next November, 30
27 October 2022 Labomar attends “Mid Small Cap Forum-Europe” in Madrid next November, 3
20 October 2022 Labomar: 9M consolidated revenues of Euro 64.5 million (+44.5%)
29 September 2022 Labomar approves H1 2022 Financial Statements
29 July 2022 New “L6” logistics hub project begins
21 July 2022 Labomar: H1 consolidated revenues of Euro 41.8 million (+36.9%)
20 July 2022 Variation to 2022 financial Calendar
12 July 2022 Labomar strengthens its partnership with Noventure
27 June 2022 Labomar attends ISMO in Paris next July, 1
12 May 2022 Labomar: new Biochetasi Acidità e Digestione study
02 May 2022 Labomar, investor events of May 2022
29 April 2022 Shareholders’ Meeting held today in addition to Board of Directors’ Meeting
22 April 2022 Labomar communicates Q1 Preliminary figures
05 April 2022 Aspi Gola® Natura e Supradyn Difese 50+, made by Labomar for Bayer, are ‘Voted Product of the Year 2022’
30 March 2022 Approval of 2021 Financial Statement and Shareholders’ Meeting Call
29 March 2022 Variation to 2022 Financial Calendar
07 March 2022 Labomar Spa is attending to Mid&Small in London 2022 next March 31
02 February 2022 Labomar becomes Issuer having shares widely spread
01 February 2022 Labomar is attending to ISMO Paris 2022 next 4.02
01 February 2022 Bayer recognises Labomar as Best External Partner 2021
24 January 2022 Labomar is attending to ISMO next 26.01
20 January 2022 Preliminary 2021 revenues
19 January 2022 2022 Financial Calendar
27 December 2021 Labomar acquires an additional 7% of Welcare Group
24 November 2021 Labomar SpA is attending on the 1st December to the Mid&Small in Milan 2021
23 November 2021 Labomar holds 100% of Labiotre Srl
19 October 2021 Labomar organizes its first Investor Day
12 October 2021 Update Financial Calendar
28 September 2021 Press Release to 1H 2021 Results
27 September 2021 1H 2021 Results
24 September 2021 Labomar is attending ISMO 2021
16 September 2021 Labomar stake in Labiotre rises to 48.8%
07 September 2021 Signed an industrial Partnership between Labomar and Sesa Group
31 August 2021 Preliminary Sales 1H 2021
27 August 2021 Update Financial Calendar
06 August 2021 Berenberg takes 3.79% stake in Labomar
06 August 2021 Internal Dealing 4
14 July 2021 Labomar acquires majority of Welcare Group
29 June 2021 Labomar signs LOI to acquire the majority of Welcare Group

Show others

Presentations

03 April 2023 Investor Access Event – Parigi_04.04.2023_Presentation
30 March 2023 Investor Call 29.03.2023_synthesis
29 March 2023 FY2022 Financial snapshot_29.03.2023_Presentation
25 November 2022 “Mid&Small in Milan”, November 30_Presentation
02 November 2022 Mid&Small Cap Forum_November 3_Presentation
29 September 2022 H1 2022 Financial Statement Results
27 June 2022 ISMO Paris, July 1_Presentation
20 May 2022 Euronext Conference in Milan 25.05.2022_Presentation
20 May 2022 German Spring Conference in Frankfurt_24.05.2022_Presentation
30 March 2022 Mid&Small in London 31.03.2022_Presentation
30 March 2022 2021 Financial statement results and 2022 guidance_30.03.2022
03 February 2022 ISMO 4.02.2022_Presentation
24 January 2022 ISMO 26.01.2022_Presentation
29 November 2021 Virgilio IR Milano_1.12.2021_Presentation
20 October 2021 Investor Days_October 18-19, 2021_Presentation
27 September 2021 1H 2021 Results_Presentation
22 July 2021 Mid&Small Conference Summer Edition_26.07.2021
30 June 2021 Italian Sustainability Week 2021_Labomar_29-30.06 e 1.07.2021_update
28 June 2021 Italian Sustainability Week 2021_Labomar_29-30.06 e 1.07.2021
24 May 2021 AIM Conference_Labomar presentation_26.05.2021
19 April 2021 Mid&Small Presentation_21.04.2021
29 March 2021 Labomar Presentation_2020 Full Year Results
10 February 2021 ESG Focus
20 November 2020 Labomar overview

Show others